Can dupilumab help lungs clear mucus better in asthma?
NCT ID NCT04743791
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether the drug dupilumab can improve how well the lungs clear mucus in people with moderate-to-severe asthma. Thirty adults will receive either dupilumab or a placebo for 12 weeks. Researchers will measure mucus clearance using a special imaging technique, along with lung function and asthma control.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Dupilumab (a biologic drug given as an injection)
What this could lead to
If successful, this could show that dupilumab improves the lungs' ability to clear mucus, pointing to a better way to control asthma symptoms.
What could go wrong
This is a small, early-phase study (30 people) focused on a specific lung measurement, not on long-term outcomes. It may not lead to new treatments or apply to all asthma patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The University of Pittsburgh Asthma Institute at UPMC
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••